Natixis Advisors, L.P. Inari Medical, Inc. Transaction History
Natixis Advisors, L.P.
- $53.5 Billion
- Q4 2024
A detailed history of Natixis Advisors, L.P. transactions in Inari Medical, Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 10,002 shares of NARI stock, worth $799,859. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,002Holding current value
$799,859% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding NARI
# of Institutions
283Shares Held
56.4MCall Options Held
412KPut Options Held
46.7K-
Black Rock Inc. New York, NY8.36MShares$669 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$450 Million0.01% of portfolio
-
Hcc Manager LLC Chicago, IL2.91MShares$233 Million93.92% of portfolio
-
Morgan Stanley New York, NY2.15MShares$172 Million0.01% of portfolio
-
State Street Corp Boston, MA2.08MShares$167 Million0.0% of portfolio
About Inari Medical, Inc.
- Ticker NARI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,389,700
- Market Cap $4.27B
- Description
- Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...